nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenofibrate—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.138	0.268	CbGbCtD
Fenofibrate—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0966	0.187	CbGbCtD
Fenofibrate—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0604	0.117	CbGbCtD
Fenofibrate—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0582	0.113	CbGbCtD
Fenofibrate—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0561	0.109	CbGbCtD
Fenofibrate—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0413	0.08	CbGbCtD
Fenofibrate—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0258	0.0499	CbGbCtD
Fenofibrate—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0236	0.0457	CbGbCtD
Fenofibrate—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0161	0.0312	CbGbCtD
Fenofibrate—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.000451	CcSEcCtD
Fenofibrate—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000218	0.000451	CcSEcCtD
Fenofibrate—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000217	0.00045	CcSEcCtD
Fenofibrate—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000216	0.000448	CcSEcCtD
Fenofibrate—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000448	CcSEcCtD
Fenofibrate—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000445	CcSEcCtD
Fenofibrate—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000213	0.000441	CcSEcCtD
Fenofibrate—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.00044	CcSEcCtD
Fenofibrate—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000212	0.000439	CcSEcCtD
Fenofibrate—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000212	0.000439	CcSEcCtD
Fenofibrate—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000212	0.000438	CcSEcCtD
Fenofibrate—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000211	0.000437	CcSEcCtD
Fenofibrate—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000437	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000211	0.000436	CcSEcCtD
Fenofibrate—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000209	0.000433	CcSEcCtD
Fenofibrate—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.000433	CcSEcCtD
Fenofibrate—Pain—Cisplatin—peripheral nervous system neoplasm	0.000209	0.000432	CcSEcCtD
Fenofibrate—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000431	CcSEcCtD
Fenofibrate—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000431	CcSEcCtD
Fenofibrate—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000206	0.000427	CcSEcCtD
Fenofibrate—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000206	0.000426	CcSEcCtD
Fenofibrate—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000205	0.000424	CcSEcCtD
Fenofibrate—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000422	CcSEcCtD
Fenofibrate—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000422	CcSEcCtD
Fenofibrate—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000422	CcSEcCtD
Fenofibrate—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000204	0.000421	CcSEcCtD
Fenofibrate—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000203	0.00042	CcSEcCtD
Fenofibrate—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000418	CcSEcCtD
Fenofibrate—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000417	CcSEcCtD
Fenofibrate—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000201	0.000417	CcSEcCtD
Fenofibrate—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000201	0.000416	CcSEcCtD
Fenofibrate—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000415	CcSEcCtD
Fenofibrate—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000414	CcSEcCtD
Fenofibrate—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.0002	0.000413	CcSEcCtD
Fenofibrate—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.0002	0.000413	CcSEcCtD
Fenofibrate—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000199	0.000412	CcSEcCtD
Fenofibrate—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000411	CcSEcCtD
Fenofibrate—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000198	0.00041	CcSEcCtD
Fenofibrate—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000409	CcSEcCtD
Fenofibrate—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000407	CcSEcCtD
Fenofibrate—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000407	CcSEcCtD
Fenofibrate—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000197	0.000407	CcSEcCtD
Fenofibrate—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000406	CcSEcCtD
Fenofibrate—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000196	0.000406	CcSEcCtD
Fenofibrate—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000195	0.000403	CcSEcCtD
Fenofibrate—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000195	0.000403	CcSEcCtD
Fenofibrate—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000193	0.0004	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000193	0.0004	CcSEcCtD
Fenofibrate—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000193	0.0004	CcSEcCtD
Fenofibrate—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000193	0.000399	CcSEcCtD
Fenofibrate—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000397	CcSEcCtD
Fenofibrate—Pain—Etoposide—peripheral nervous system neoplasm	0.000191	0.000396	CcSEcCtD
Fenofibrate—Constipation—Etoposide—peripheral nervous system neoplasm	0.000191	0.000396	CcSEcCtD
Fenofibrate—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000396	CcSEcCtD
Fenofibrate—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000396	CcSEcCtD
Fenofibrate—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.000395	CcSEcCtD
Fenofibrate—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000393	CcSEcCtD
Fenofibrate—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00019	0.000392	CcSEcCtD
Fenofibrate—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000189	0.000391	CcSEcCtD
Fenofibrate—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000189	0.00039	CcSEcCtD
Fenofibrate—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.00039	CcSEcCtD
Fenofibrate—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000386	CcSEcCtD
Fenofibrate—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000385	CcSEcCtD
Fenofibrate—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000384	CcSEcCtD
Fenofibrate—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.000382	CcSEcCtD
Fenofibrate—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000382	CcSEcCtD
Fenofibrate—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000184	0.000382	CcSEcCtD
Fenofibrate—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000184	0.00038	CcSEcCtD
Fenofibrate—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000379	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000183	0.000379	CcSEcCtD
Fenofibrate—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000183	0.000378	CcSEcCtD
Fenofibrate—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000182	0.000377	CcSEcCtD
Fenofibrate—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000377	CcSEcCtD
Fenofibrate—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000377	CcSEcCtD
Fenofibrate—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000181	0.000374	CcSEcCtD
Fenofibrate—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000181	0.000374	CcSEcCtD
Fenofibrate—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00018	0.000372	CcSEcCtD
Fenofibrate—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00018	0.000372	CcSEcCtD
Fenofibrate—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.00037	CcSEcCtD
Fenofibrate—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000178	0.000368	CcSEcCtD
Fenofibrate—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000367	CcSEcCtD
Fenofibrate—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000366	CcSEcCtD
Fenofibrate—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000177	0.000366	CcSEcCtD
Fenofibrate—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000177	0.000366	CcSEcCtD
Fenofibrate—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000366	CcSEcCtD
Fenofibrate—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000366	CcSEcCtD
Fenofibrate—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000365	CcSEcCtD
Fenofibrate—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000176	0.000364	CcSEcCtD
Fenofibrate—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000175	0.000363	CcSEcCtD
Fenofibrate—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000363	CcSEcCtD
Fenofibrate—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000361	CcSEcCtD
Fenofibrate—Rash—Vincristine—peripheral nervous system neoplasm	0.000174	0.00036	CcSEcCtD
Fenofibrate—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000174	0.00036	CcSEcCtD
Fenofibrate—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000174	0.00036	CcSEcCtD
Fenofibrate—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000174	0.000359	CcSEcCtD
Fenofibrate—Headache—Vincristine—peripheral nervous system neoplasm	0.000173	0.000358	CcSEcCtD
Fenofibrate—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000356	CcSEcCtD
Fenofibrate—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000353	CcSEcCtD
Fenofibrate—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00017	0.000352	CcSEcCtD
Fenofibrate—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000352	CcSEcCtD
Fenofibrate—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000167	0.000346	CcSEcCtD
Fenofibrate—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000341	CcSEcCtD
Fenofibrate—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000165	0.000341	CcSEcCtD
Fenofibrate—Nausea—Vincristine—peripheral nervous system neoplasm	0.000164	0.00034	CcSEcCtD
Fenofibrate—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000339	CcSEcCtD
Fenofibrate—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000339	CcSEcCtD
Fenofibrate—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000338	CcSEcCtD
Fenofibrate—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000336	CcSEcCtD
Fenofibrate—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000333	CcSEcCtD
Fenofibrate—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000161	0.000332	CcSEcCtD
Fenofibrate—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000332	CcSEcCtD
Fenofibrate—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000332	CcSEcCtD
Fenofibrate—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000329	CcSEcCtD
Fenofibrate—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000158	0.000328	CcSEcCtD
Fenofibrate—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000326	CcSEcCtD
Fenofibrate—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000326	CcSEcCtD
Fenofibrate—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000323	CcSEcCtD
Fenofibrate—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000155	0.000321	CcSEcCtD
Fenofibrate—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000155	0.00032	CcSEcCtD
Fenofibrate—Rash—Cisplatin—peripheral nervous system neoplasm	0.000154	0.000319	CcSEcCtD
Fenofibrate—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000154	0.000318	CcSEcCtD
Fenofibrate—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000318	CcSEcCtD
Fenofibrate—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000318	CcSEcCtD
Fenofibrate—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000153	0.000317	CcSEcCtD
Fenofibrate—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000316	CcSEcCtD
Fenofibrate—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000314	CcSEcCtD
Fenofibrate—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000313	CcSEcCtD
Fenofibrate—Tension—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000312	CcSEcCtD
Fenofibrate—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000309	CcSEcCtD
Fenofibrate—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000308	CcSEcCtD
Fenofibrate—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000307	CcSEcCtD
Fenofibrate—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000148	0.000306	CcSEcCtD
Fenofibrate—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000306	CcSEcCtD
Fenofibrate—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000305	CcSEcCtD
Fenofibrate—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000302	CcSEcCtD
Fenofibrate—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000145	0.0003	CcSEcCtD
Fenofibrate—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000299	CcSEcCtD
Fenofibrate—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000296	CcSEcCtD
Fenofibrate—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000295	CcSEcCtD
Fenofibrate—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000142	0.000294	CcSEcCtD
Fenofibrate—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000294	CcSEcCtD
Fenofibrate—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000294	CcSEcCtD
Fenofibrate—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000294	CcSEcCtD
Fenofibrate—Rash—Etoposide—peripheral nervous system neoplasm	0.000141	0.000292	CcSEcCtD
Fenofibrate—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000141	0.000292	CcSEcCtD
Fenofibrate—Headache—Etoposide—peripheral nervous system neoplasm	0.00014	0.00029	CcSEcCtD
Fenofibrate—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.00029	CcSEcCtD
Fenofibrate—Tension—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000289	CcSEcCtD
Fenofibrate—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000287	CcSEcCtD
Fenofibrate—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000286	CcSEcCtD
Fenofibrate—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000286	CcSEcCtD
Fenofibrate—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000285	CcSEcCtD
Fenofibrate—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000285	CcSEcCtD
Fenofibrate—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000283	CcSEcCtD
Fenofibrate—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000281	CcSEcCtD
Fenofibrate—Cough—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000278	CcSEcCtD
Fenofibrate—Nausea—Etoposide—peripheral nervous system neoplasm	0.000133	0.000275	CcSEcCtD
Fenofibrate—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000275	CcSEcCtD
Fenofibrate—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000273	CcSEcCtD
Fenofibrate—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000272	CcSEcCtD
Fenofibrate—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000271	CcSEcCtD
Fenofibrate—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000271	CcSEcCtD
Fenofibrate—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000271	CcSEcCtD
Fenofibrate—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.00013	0.00027	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000269	CcSEcCtD
Fenofibrate—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000268	CcSEcCtD
Fenofibrate—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000265	CcSEcCtD
Fenofibrate—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000265	CcSEcCtD
Fenofibrate—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000264	CcSEcCtD
Fenofibrate—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000263	CcSEcCtD
Fenofibrate—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.00026	CcSEcCtD
Fenofibrate—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000126	0.00026	CcSEcCtD
Fenofibrate—Infection—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000258	CcSEcCtD
Fenofibrate—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000257	CcSEcCtD
Fenofibrate—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000255	CcSEcCtD
Fenofibrate—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000254	CcSEcCtD
Fenofibrate—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000254	CcSEcCtD
Fenofibrate—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000253	CcSEcCtD
Fenofibrate—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000252	CcSEcCtD
Fenofibrate—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000251	CcSEcCtD
Fenofibrate—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000251	CcSEcCtD
Fenofibrate—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000251	CcSEcCtD
Fenofibrate—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000251	CcSEcCtD
Fenofibrate—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.00025	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000249	CcSEcCtD
Fenofibrate—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000248	CcSEcCtD
Fenofibrate—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000247	CcSEcCtD
Fenofibrate—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000245	CcSEcCtD
Fenofibrate—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000243	CcSEcCtD
Fenofibrate—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.00024	CcSEcCtD
Fenofibrate—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000239	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000237	CcSEcCtD
Fenofibrate—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000236	CcSEcCtD
Fenofibrate—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000235	CcSEcCtD
Fenofibrate—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000235	CcSEcCtD
Fenofibrate—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000234	CcSEcCtD
Fenofibrate—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000233	CcSEcCtD
Fenofibrate—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000233	CcSEcCtD
Fenofibrate—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000232	CcSEcCtD
Fenofibrate—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000231	CcSEcCtD
Fenofibrate—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000231	CcSEcCtD
Fenofibrate—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000229	CcSEcCtD
Fenofibrate—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000229	CcSEcCtD
Fenofibrate—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000226	CcSEcCtD
Fenofibrate—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000224	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000224	CcSEcCtD
Fenofibrate—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000224	CcSEcCtD
Fenofibrate—Pain—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000222	CcSEcCtD
Fenofibrate—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000222	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000219	CcSEcCtD
Fenofibrate—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000217	CcSEcCtD
Fenofibrate—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000216	CcSEcCtD
Fenofibrate—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000214	CcSEcCtD
Fenofibrate—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000214	CcSEcCtD
Fenofibrate—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000214	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000212	CcSEcCtD
Fenofibrate—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000211	CcSEcCtD
Fenofibrate—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000209	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000207	CcSEcCtD
Fenofibrate—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000207	CcSEcCtD
Fenofibrate—Urticaria—Epirubicin—peripheral nervous system neoplasm	9.97e-05	0.000206	CcSEcCtD
Fenofibrate—Pain—Doxorubicin—peripheral nervous system neoplasm	9.93e-05	0.000205	CcSEcCtD
Fenofibrate—Constipation—Doxorubicin—peripheral nervous system neoplasm	9.93e-05	0.000205	CcSEcCtD
Fenofibrate—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	9.92e-05	0.000205	CcSEcCtD
Fenofibrate—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	9.92e-05	0.000205	CcSEcCtD
Fenofibrate—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	9.57e-05	0.000198	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	9.5e-05	0.000196	CcSEcCtD
Fenofibrate—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	9.25e-05	0.000191	CcSEcCtD
Fenofibrate—Urticaria—Doxorubicin—peripheral nervous system neoplasm	9.23e-05	0.000191	CcSEcCtD
Fenofibrate—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	9.18e-05	0.00019	CcSEcCtD
Fenofibrate—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	9.18e-05	0.00019	CcSEcCtD
Fenofibrate—Asthenia—Epirubicin—peripheral nervous system neoplasm	9e-05	0.000186	CcSEcCtD
Fenofibrate—Pruritus—Epirubicin—peripheral nervous system neoplasm	8.88e-05	0.000184	CcSEcCtD
Fenofibrate—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	8.59e-05	0.000178	CcSEcCtD
Fenofibrate—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	8.56e-05	0.000177	CcSEcCtD
Fenofibrate—Asthenia—Doxorubicin—peripheral nervous system neoplasm	8.33e-05	0.000172	CcSEcCtD
Fenofibrate—Dizziness—Epirubicin—peripheral nervous system neoplasm	8.3e-05	0.000172	CcSEcCtD
Fenofibrate—Pruritus—Doxorubicin—peripheral nervous system neoplasm	8.22e-05	0.00017	CcSEcCtD
Fenofibrate—Vomiting—Epirubicin—peripheral nervous system neoplasm	7.98e-05	0.000165	CcSEcCtD
Fenofibrate—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	7.95e-05	0.000164	CcSEcCtD
Fenofibrate—Rash—Epirubicin—peripheral nervous system neoplasm	7.91e-05	0.000164	CcSEcCtD
Fenofibrate—Dermatitis—Epirubicin—peripheral nervous system neoplasm	7.91e-05	0.000164	CcSEcCtD
Fenofibrate—Headache—Epirubicin—peripheral nervous system neoplasm	7.86e-05	0.000163	CcSEcCtD
Fenofibrate—Dizziness—Doxorubicin—peripheral nervous system neoplasm	7.68e-05	0.000159	CcSEcCtD
Fenofibrate—Nausea—Epirubicin—peripheral nervous system neoplasm	7.45e-05	0.000154	CcSEcCtD
Fenofibrate—Vomiting—Doxorubicin—peripheral nervous system neoplasm	7.38e-05	0.000153	CcSEcCtD
Fenofibrate—Rash—Doxorubicin—peripheral nervous system neoplasm	7.32e-05	0.000151	CcSEcCtD
Fenofibrate—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	7.32e-05	0.000151	CcSEcCtD
Fenofibrate—Headache—Doxorubicin—peripheral nervous system neoplasm	7.27e-05	0.00015	CcSEcCtD
Fenofibrate—Nausea—Doxorubicin—peripheral nervous system neoplasm	6.9e-05	0.000143	CcSEcCtD
